Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro

• Published in: Experimental Oncology
• Date: 2007
• Main Authors: Yerushalmi, R., Nordenberg, J., Beery, E., Uziel, O., Lahav, M., Luria, D., Fenig, E.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2007
• Subjects: Original contributions
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/138577
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro / R. Yerushalmi, J. Nordenberg, E. Beery, O. Uziel, M. Lahav, D. Luria, E. Fenig // Experimental Oncology. — 2007. — Т. 29, № 2. — С. 126–131. — Бібліогр.: 29 назв. — англ.

Little is known about the interaction of novel anticancer drugs with other treatment modalities. The aim of this study was to examine the effect of combining imatinib mesylate (STI-571) with radiation or cisplatin on the survival of two human solid tumor cell lines – SKNMC cells derived from Ewing s...